Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities

Background: The COVID-19 pandemic caused by the SARS-CoV-2 virus has left infected patients with comorbidities in severe and deadly conditions. Hypertension is a non-communicable disease (NCD) and is one of the most common comorbidities observed in COVID-19 patients. Purpose: This study aims to unde...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nina Widyasari, Hari Basuki, Chatarina Umbul Wahjuni
Formato:	article
Lenguaje:	EN ID
Publicado:	Universitas Airlangga 2021
Materias:	coronavirus disease 2019 hypertension mortality risk factor Public aspects of medicine RA1-1270 Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/f3e023f03c474fdc979152f5223ee887
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f3e023f03c474fdc979152f5223ee887
record_format	dspace
spelling	oai:doaj.org-article:f3e023f03c474fdc979152f5223ee8872021-12-02T17:41:50ZAssociated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities2301-71712541-092X10.20473/jbe.V9I22021.130-139https://doaj.org/article/f3e023f03c474fdc979152f5223ee8872021-05-01T00:00:00Zhttps://e-journal.unair.ac.id/JBE/article/view/26379https://doaj.org/toc/2301-7171https://doaj.org/toc/2541-092XBackground: The COVID-19 pandemic caused by the SARS-CoV-2 virus has left infected patients with comorbidities in severe and deadly conditions. Hypertension is a non-communicable disease (NCD) and is one of the most common comorbidities observed in COVID-19 patients. Purpose: This study aims to understand the relationship between hypertension and the risk of death through COVID-19. Method: The study employed a systematic review of journals. Journals and articles related to hypertension and COVID-19 were collected and analyzed. The inclusion criteria was COVID-19 articles pertaining to hypertensive patients, and the exclusion criteria was articles that did not use English as well as those that did not display full text. Result: Hypertension is a multifactorial disease. The presence of hypertension is often not realized by the sufferer. A COVID-19 infection can worsen the condition of the person and can cause damage to vital organs. The use of antihypertensive drugs of the angiotensin-converting enzyme inhibitor (ACEI) and the angiotensin receptor blocker (ARB) groups can be continued to be administered to hypertensive patients. There should be no cause for concern for these patients to develop COVID-19 infections by taking these drugs. Conclusion: The risk of developing hypertension is that it can cause organ damage and lead to various complications. The SARS-CoV-2 infection in people with hypertension as a comorbidity, could worsen the condition of the individual until death occurs. Thus, hypertension management is necessary to properly minimize the severity.Nina WidyasariHari BasukiChatarina Umbul WahjuniUniversitas Airlanggaarticlecoronavirus disease 2019hypertensionmortalityrisk factorPublic aspects of medicineRA1-1270Infectious and parasitic diseasesRC109-216ENIDJurnal Berkala Epidemiologi, Vol 9, Iss 2, Pp 130-139 (2021)
institution	DOAJ
collection	DOAJ
language	EN ID
topic	coronavirus disease 2019 hypertension mortality risk factor Public aspects of medicine RA1-1270 Infectious and parasitic diseases RC109-216
spellingShingle	coronavirus disease 2019 hypertension mortality risk factor Public aspects of medicine RA1-1270 Infectious and parasitic diseases RC109-216 Nina Widyasari Hari Basuki Chatarina Umbul Wahjuni Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities
description	Background: The COVID-19 pandemic caused by the SARS-CoV-2 virus has left infected patients with comorbidities in severe and deadly conditions. Hypertension is a non-communicable disease (NCD) and is one of the most common comorbidities observed in COVID-19 patients. Purpose: This study aims to understand the relationship between hypertension and the risk of death through COVID-19. Method: The study employed a systematic review of journals. Journals and articles related to hypertension and COVID-19 were collected and analyzed. The inclusion criteria was COVID-19 articles pertaining to hypertensive patients, and the exclusion criteria was articles that did not use English as well as those that did not display full text. Result: Hypertension is a multifactorial disease. The presence of hypertension is often not realized by the sufferer. A COVID-19 infection can worsen the condition of the person and can cause damage to vital organs. The use of antihypertensive drugs of the angiotensin-converting enzyme inhibitor (ACEI) and the angiotensin receptor blocker (ARB) groups can be continued to be administered to hypertensive patients. There should be no cause for concern for these patients to develop COVID-19 infections by taking these drugs. Conclusion: The risk of developing hypertension is that it can cause organ damage and lead to various complications. The SARS-CoV-2 infection in people with hypertension as a comorbidity, could worsen the condition of the individual until death occurs. Thus, hypertension management is necessary to properly minimize the severity.
format	article
author	Nina Widyasari Hari Basuki Chatarina Umbul Wahjuni
author_facet	Nina Widyasari Hari Basuki Chatarina Umbul Wahjuni
author_sort	Nina Widyasari
title	Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities
title_short	Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities
title_full	Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities
title_fullStr	Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities
title_full_unstemmed	Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities
title_sort	associated risk of death from covid-19 infection in patients with hypertensive co-morbidities
publisher	Universitas Airlangga
publishDate	2021
url	https://doaj.org/article/f3e023f03c474fdc979152f5223ee887
work_keys_str_mv	AT ninawidyasari associatedriskofdeathfromcovid19infectioninpatientswithhypertensivecomorbidities AT haribasuki associatedriskofdeathfromcovid19infectioninpatientswithhypertensivecomorbidities AT chatarinaumbulwahjuni associatedriskofdeathfromcovid19infectioninpatientswithhypertensivecomorbidities
_version_	1718379680731496448

Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities

Ejemplares similares